Anchor Marcelle Fontenot Shares Cancer Diagnosis

The Lafayette news anchor is recovering after surgery to address a diagnosis of ductal carcinoma in situ.

Updated on Oct. 16, 2026 in Cancer

Bold flat-color editorial illustration in deep red and cream, featuring an abstract geometric arc evoking clinical diagnostic processes.
Lafayette news anchor Marcelle Fontenot is recovering from surgery after being diagnosed with ductal carcinoma in situ during a routine screening. AI Illustration. Upload story photo >

Following a routine mammogram in August 2026, Marcelle Fontenot received a diagnosis of ductal carcinoma in situ. The Lafayette journalist is now two weeks post-operation after undergoing surgery to remove the affected milk duct.

Why it matters

The diagnosis highlights the importance of proactive health screenings, as Fontenot had been receiving regular mammograms since age 25 due to a family history of breast cancer.

A biopsy confirmed the presence of cancerous cells in the milk duct. Fontenot began routine mammograms at age 25, significantly earlier than standard screening guidelines.

The players

Marcelle Fontenot

She is a prominent news anchor based in Lafayette who reports on events across the Acadiana region.

The details

A surgeon successfully removed the milk duct containing abnormal cells after the cancer was identified during a routine screening. Fontenot plans to undergo radiation therapy in the coming weeks as part of her treatment recovery.

Timeline

  1. Age 25: Fontenot began receiving routine mammograms.

  2. August 2026: A routine mammogram led to the initial cancer diagnosis.

  3. October 2026: Fontenot publicly disclosed her diagnosis.

The Big Picture

This case follows the pattern set by the American Cancer Society breast cancer screening guidelines regarding the efficacy of early detection in high-risk individuals. By identifying the cancer early, the patient was able to proceed directly to surgical intervention.

This diagnosis emphasizes the critical role of personal health monitoring for those with a documented family history of breast cancer. Patients are encouraged to discuss tailored screening schedules with their physicians, especially if they have relatives who have faced similar diagnoses.

The takeaway

Early detection remains the most effective tool in managing breast cancer outcomes. Maintaining a consistent screening schedule, especially when family history is present, is a vital proactive step for long-term health.

Further reading

Learn more about the latest research and support resources in the Lafayette Cancer section.

Source note: This article includes information reported by Acadiananewsfirst.